Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ANAFRANIL | 25MG | TABLET | Resolved | 2021-02-26 | 2021-03-15 | 134799 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2021-02-26 | 2021-03-24 | 134802 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-02-26 | 2021-08-23 | 134811 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134814 |
| APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134817 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2021-02-26 | 2021-03-24 | 134820 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-02-26 | 2021-03-19 | 134823 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-03-05 | 2021-05-26 | 135148 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-03-05 | 2021-03-15 | 135153 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-03-05 | 2021-03-15 | 135156 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-03-05 | 2021-03-29 | 135162 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-03-05 | 2021-04-12 | 135167 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2021-03-05 | 2021-06-21 | 135171 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-03-05 | 2021-03-15 | 135174 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2021-03-05 | 2021-05-17 | 135177 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2021-03-05 | 2021-06-14 | 135181 |
| APO-QUINAPRIL | 5MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-29 | 135685 |
| APO-QUINAPRIL | 10MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-29 | 135689 |
| APO-QUINAPRIL | 20MG | TABLET | Actual shortage | 2021-03-15 | 2021-12-03 | 135692 |
| APO-QUINAPRIL | 40MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-30 | 135695 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |